Section II: hematolymphoid malignancies
Conclusions With a marked reduction in the cost of DNA sequencing, new molecular genetic
tests based on NGS technology will gradually find their way into clinical laboratories as …
tests based on NGS technology will gradually find their way into clinical laboratories as …
[PDF][PDF] Acute lymphoblastic leukemia: Genetic events and molecular signatures
Y Hu - Am J Biomed Sci, 2014 - nwpii.com
Childhood or pediatric acute precursor B cell lymphoblastic leukemia (B-ALL) is the most
prevalent hematological malignancy in children. Previous studies have revealed …
prevalent hematological malignancy in children. Previous studies have revealed …
Molecular background and therapeutic perspectives of acute lymphoblastic leukemia BCR-ABL1-like
J Madzio, A Pastorczak… - Hematology in Clinical …, 2014 - journals.viamedica.pl
BCR-ABL1-like acute lymphoblastic leukemia (ALL) is newly identified subtype of high-risk B-
cell progenitor acute lymphoblastic leukemia (BCP-ALL), which exhibit gene expression …
cell progenitor acute lymphoblastic leukemia (BCP-ALL), which exhibit gene expression …
[图书][B] Contribució de la citogenètica molecular i les tècniques d'estimulació i separació cel· lular a l'estudi de les neoplàsies hematològiques limfoides d'origen B
J Sánchez García - 2014 - ddd.uab.cat
L'estudi citogenètic de les neoplàsies hematològiques és de gran importància en la pràctica
clínica des del punt de vista diagnòstic, pronòstic i patogenètic. La identificació d'alteracions …
clínica des del punt de vista diagnòstic, pronòstic i patogenètic. La identificació d'alteracions …
[PDF][PDF] A gyermekkori akut limfoid leukémiára való hajlam genetikai, valamint a kezelésre adott válasz farmakogenetikai vizsgálata
O Lautner-Csorba - 2014 - repo.lib.semmelweis.hu
A genetikai vizsgálatok egyre nagyobb teret hódítanak a 21. századi orvostudomány
területén. Az embert meghatározó genetikai „háttértár” megfejtése iránti kutatói érdeklődés …
területén. Az embert meghatározó genetikai „háttértár” megfejtése iránti kutatói érdeklődés …
Thymic Stromal Lymphopoietin (TSLP) TSLP in Allergy, Autoimmunity, and Cancer
SF Ziegler, F Roan, BD Bell, TA Stoklasek… - … Frontiers: Regulation of …, 2014 - Springer
Originally shown to promote the growth and activation of B cells, thymic stromal
lymphopoietin (TSLP) is now known to have wide-ranging impacts on both hematopoietic …
lymphopoietin (TSLP) is now known to have wide-ranging impacts on both hematopoietic …
Podłoże molekularne i perspektywy terapeutyczne ostrej białaczki limfoblastycznej BCR-ABL1-like
JT Madzio, A Pastorczak, W Młynarski - Hematologia, 2014 - publicum.umed.lodz.pl
Białaczka BCR-ABL1-like jest nowo wyodrębnionym podtypem ostrej białaczki
limfoblastycznej (ALL) wysokiego ryzyka, wywodzącym się z komórek prekursorowych …
limfoblastycznej (ALL) wysokiego ryzyka, wywodzącym się z komórek prekursorowych …
[PDF][PDF] Down syndrome acute lymphoblastic leukemia is characterized by loss of ETS-related gene (ERG) repression
TD Buitenkamp, MM van den Heuvel-Eibrink… - Clinical Relevance of …, 2014 - core.ac.uk
Children with Down syndrome (DS) have an increased risk to develop B-cell precursor acute
lymphoblastic leukemia (BCP-ALL). The driving molecular events in DS ALL pathogenesis …
lymphoblastic leukemia (BCP-ALL). The driving molecular events in DS ALL pathogenesis …
Clinical Relevance of Genetic Alterations in Acute Lymphoblastic Leukemia in Children with Down syndrome
T BuiTenkamp - 2014 - repub.eur.nl
__Abstract__ Hematopoiesis encompasses the process by which mature peripheral blood
cells are generated by differentiation of hematopoietic stem cells (HSC) in the bone marrow …
cells are generated by differentiation of hematopoietic stem cells (HSC) in the bone marrow …